► Subscribe to the Financial Times on YouTube: http://bit.ly/FTimeSubs
Johnson & Johnson is hunting for potential acquisitions as it seeks to spend $18bn of cash. Perhaps healthcare activists should turn their guns to Switzerland, says Lex’s Rob Armstrong, instead of focusing on the US-based pharma group.
For more video content from the Financial Times, visit http://www.FT.com/video
Twitter https://twitter.com/ftvideo
Facebook https://www.facebook.com/financialtimes
